Core Viewpoint - Health 160 (02656) experienced a significant decline of nearly 40%, retracting most of its gains for the year, with its market capitalization briefly falling below HKD 20 billion [1] Company Overview - Health 160 is an experienced wholesale distributor of pharmaceutical and health products in China and a leading provider of integrated digital healthcare services [1] - The company offers a variety of pharmaceutical health products and comprehensive digital health solutions [1] - As of March 31, 2025, Health 160's platform has connected over 44,600 healthcare institutions, including more than 14,400 hospitals and over 30,200 grassroots healthcare institutions [1] Market Activity - Health 160 was listed on September 17, 2025 [1] - According to previous reports, companies with high lock-up release market values may face stock price pressure before and after the release [1] - Health 160 is set to unlock 267 million shares on September 17, which represents 79% of its circulating shares [1]
港股异动 | 健康160(02656)重挫近40% 回吐年内多数涨幅 总市值一度跌穿200亿港元